Redmile Group

Redmile Group, LLC is a healthcare-focused investment firm formed in 2007. Headquartered in Larkspur, California, with an additional office in New York, it's registered with the SEC and manages approximately $4.7 billion in client assets. The firm makes venture, growth, and crossover investments exclusively in U.S. and non-U.S. healthcare companies, spanning private and public markets, and in limited circumstances provides consulting services to portfolio companies alongside capital. Redmile's portfolio includes biotech and life sciences companies like Verve Therapeutics, Prime Medicine, Nurix Therapeutics, Kymera Therapeutics, Absci, and Repare Therapeutics, alongside public holdings such as Amicus Therapeutics and Fate Therapeutics. Its crossover approach provides continuity of capital from private venture stages through public markets.